Skip to main content
I

IMRICOR MEDICAL SYSTEMS INC. — Investor Relations & Filings

Ticker · IMR ASX Manufacturing
Open in API
Filings indexed 550 across all filing types
Latest filing 2026-04-27 Interim / Quarterly Rep…
Country AU Australia
Listing ASX IMR

About IMRICOR MEDICAL SYSTEMS INC.

https://imricor.com

Imricor Medical Systems Inc. specializes in the development and commercialization of MRI-compatible medical devices designed for cardiac electrophysiology (EP) procedures. The company’s primary focus is enabling interventional cardiac ablation procedures to be performed under real-time MRI guidance, offering an alternative to traditional X-ray fluoroscopy. Key products include the Vision-MR Ablation Catheter and the Advantage-MR EP Recorder/Stimulator System, which are engineered to operate safely and effectively within the high-magnetic-field environment of an MRI scanner. By utilizing real-time MRI, the company aims to provide clinicians with superior soft-tissue visualization and eliminate the ionizing radiation exposure associated with conventional fluoroscopic methods. These technologies are intended to improve the precision and efficacy of treatments for cardiac arrhythmias, such as atrial fibrillation and flutter.

Recent filings

Filing Released Lang Actions
Imricor Q1 CY26 Quarterly Activities Report and Appendix 4C 10 pages 799.7KB
Interim / Quarterly Report Classification · 1% confidence The document is an 'Appendix 4C Quarterly Cash Flow Report' combined with a 'Quarterly Activities Report' for Imricor Medical Systems. It provides detailed financial data (cash flows, operating expenses, cash position) and operational updates for the quarter ended March 31, 2026. As it contains substantive financial statements and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. Q1 2026
2026-04-27 English
Amendment to Form 10 160 pages 1.4MB
Regulatory Filings Classification · 1% confidence The document is an SEC filing titled “Amendment No. 1 to Form 10,” i.e., a Registration Statement amendment under the Securities Exchange Act of 1934. It is not an earnings release, annual report (10-K), proxy or AGM material, nor a notice of dividend, M&A, or management change. There is no specific category for Form 10 in the taxonomy, so by fallback rules it is classified as a general regulatory filing (RNS).
2026-04-26 English
Notification regarding unquoted securities - IMR 6 pages 18.9KB
Share Issue/Capital Change Classification · 1% confidence The document is an ASX Appendix 3G notice detailing the issue of unquoted equity securities (employee options) under an incentive scheme. This is an announcement of a change in the company’s capital structure (issuance of new securities), which falls under the Share Issue/Capital Change category.
2026-04-15 English
Imricor Submits NorthStar for U.S. Pediatric Expansion 2 pages 318.1KB
Regulatory Filings
2026-04-07 English
Appendix 4G and Corporate Governance Statement 24 pages 874.2KB
Regulatory Filings
2026-03-26 English
Annual Report to shareholders 78 pages 10.1MB
Regulatory Filings
2026-03-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.